Data availability
The data that support the findings of this study are available from the corresponding author upon reasonable request after approval by the SIGNAL study investigators.
Change history
14 February 2023
A Correction to this paper has been published: https://doi.org/10.1007/s00415-023-11606-4
References
Charidimou A, Imaizumi T, Moulin S et al (2017) Brain hemorrhage recurrence, small vessel disease type, and cerebral microbleeds: a meta-analysis. Neurology 89(8):820–829
Charidimou A, Frosch MP, Al-Shahi Salman R et al (2019) Advancing diagnostic criteria for sporadic cerebral amyloid angiopathy: study protocol for a multicenter MRI-pathology validation of Boston criteria v2.0. Int J Stroke 14(9):956–971
Charidimou A, Boulouis G, Frosch MP et al (2022) The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study. Lancet Neurol 21(8):714–725
Shirzadi Z, Yau WW, Schultz SA et al (2022) Progressive white matter injury in preclinical Dutch cerebral amyloid angiopathy. Ann Neurol 92(3):358–363
Acknowledgements
This work was undertaken at UCLH/UCL, which receives a proportion of funding from the Department of Health’s National Institute for Health Research (NIHR) Biomedical Research Centres funding scheme.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
We declare no relevant conflicts of interest.
Ethical standard
This retrospective study, based on a review of existing medical records, was approved as a service evaluation and granted a waiver of consent by the University College Hospital NHS Foundation Trust Governance Review Board (code: 5-201920-SE).
Additional information
The original online version of this article was revised: The text “A further 11 patients (91%)” Should read “A further 11 patients (9%)” in the third sentence of the third paragraph
Rights and permissions
About this article
Cite this article
Du, Y., Zhang, W., Locatelli, M. et al. The Boston criteria version 2.0 increase the proportion of lobar intracerebral haemorrhage classified as probable cerebral amyloid angiopathy. J Neurol 270, 3243–3245 (2023). https://doi.org/10.1007/s00415-023-11565-w
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-023-11565-w